Archer Investment Corp Laboratory Corp Of America Holdings Transaction History

Archer Investment Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$211.93 - $241.33 $93,249 - $106,185	-440 Reduced 10.02%	3,952 $954 Million
Q1 2022 May 12, 2022	SELL	$259.82 - $298.18 $2,598 - $2,981	-10 Reduced 0.23%	4,392 $1.16 Billion
Q4 2021 Feb 09, 2022	BUY	$271.6 - $314.21 $1,086 - $1,256	4 Added 0.09%	4,402 $1.38 Billion
Q3 2021 Oct 29, 2021	SELL	$274.82 - $308.34 $7,420 - $8,325	-27 Reduced 0.61%	4,398 $1.24 Billion
Q2 2021 Aug 05, 2021	SELL	$251.87 - $278.14 $8,815 - $9,734	-35 Reduced 0.78%	4,425 $1.22 Billion
Q1 2021 May 14, 2021	SELL	$204.88 - $255.03 $47,122 - $58,656	-230 Reduced 4.9%	4,460 $1.14 Billion
Q1 2020 May 07, 2020	BUY	$104.32 - $195.28 $489,260 - $915,863	4,690 New	4,690 $593,000
Q3 2019 Apr 01, 2020	SELL	$159.77 - $178.1 $343,505 - $382,915	-2,150 Closed	0 $0
Q2 2019 May 19, 2020	SELL	$144.16 - $172.9 $14,416 - $17,290	-100 Reduced 4.44%	2,150 $372,000
Q1 2019 Apr 09, 2020	BUY	$123.7 - $156.3 $30,925 - $39,075	250 Added 12.5%	2,250 $344,000
Q4 2018 Apr 06, 2020	BUY	$120.82 - $174.09 $241,640 - $348,180	2,000 New	2,000 $253,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Archer Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Archer Investment Corp with notifications on news.